Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 2
2005 6
2006 4
2009 1
2010 3
2011 3
2012 9
2013 7
2014 8
2015 20
2016 21
2017 7
2018 9
2019 23
2020 13
2021 19
2022 32
2023 28
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.
Nose Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kawashima A, Haruna M, Hirata M, Ueyama A, Iwahori K, Satoh T, Kurokawa Y, Eguchi H, Doki Y, Wada H. Nose Y, et al. Among authors: yamamoto k. Cancer Immunol Immunother. 2023 Jan;72(1):169-181. doi: 10.1007/s00262-022-03240-2. Epub 2022 Jul 1. Cancer Immunol Immunother. 2023. PMID: 35776160 Free PMC article.
Laparoscopic Gastrectomy for Advanced Gastric Cancer.
Yamamoto K, Omori T, Kurokawa Y, Takeno A, Akamaru Y, Demura K, Okada K, Kishi K, Saito T, Takahashi T, Eguchi H, Doki Y. Yamamoto K, et al. Am Surg. 2023 Dec;89(12):5660-5668. doi: 10.1177/00031348221114042. Epub 2023 Apr 26. Am Surg. 2023. PMID: 37127301
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, Honma K, Yamashita K, Saito T, Tanaka K, Yamamoto K, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Wada H, Morii E, Eguchi H, Doki Y. Hayashi Y, et al. Among authors: yamamoto k. Br J Cancer. 2023 Jun;128(12):2175-2185. doi: 10.1038/s41416-023-02235-9. Epub 2023 Apr 4. Br J Cancer. 2023. PMID: 37016103 Free PMC article.
Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes.
Nose Y, Makino T, Tatsumi M, Tanaka K, Yamashita K, Noma T, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Nakajima K, Eguchi H, Doki Y. Nose Y, et al. Among authors: yamamoto k. Br J Cancer. 2023 May;128(10):1879-1887. doi: 10.1038/s41416-023-02151-y. Epub 2023 Feb 25. Br J Cancer. 2023. PMID: 36841907 Free PMC article.
Perioperative Ghrelin Administration Attenuates Postoperative Skeletal Muscle Loss in Patients Undergoing Esophagectomy for Esophageal Cancer: Secondary Analysis of a Randomized Controlled Trial.
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Among authors: yamamoto k. Ann Surg Oncol. 2022 Jun;29(6):3604-3612. doi: 10.1245/s10434-022-11436-0. Epub 2022 Feb 20. Ann Surg Oncol. 2022. PMID: 35187621 Clinical Trial.
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors.
Teranishi R, Takahashi T, Obata Y, Nishida T, Ohkubo S, Kazuno H, Saito Y, Serada S, Fujimoto M, Kurokawa Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Nakajima K, Hirota S, Naka T, Eguchi H, Doki Y. Teranishi R, et al. Among authors: yamamoto k. Int J Cancer. 2023 Jun 15;152(12):2580-2593. doi: 10.1002/ijc.34461. Epub 2023 Feb 21. Int J Cancer. 2023. PMID: 36752576
Podocytes are lost from glomeruli before completing apoptosis.
Yamamoto K, Okabe M, Tanaka K, Yokoo T, Pastan I, Araoka T, Osafune K, Udagawa T, Koizumi M, Matsusaka T. Yamamoto K, et al. Am J Physiol Renal Physiol. 2022 Nov 1;323(5):F515-F526. doi: 10.1152/ajprenal.00080.2022. Epub 2022 Sep 1. Am J Physiol Renal Physiol. 2022. PMID: 36049065 Free PMC article.
Ultra-thin surgical swab: its development and clinical application.
Hayashi Y, Akai K, Fujii S, Ueda T, Maeda I, Takahashi T, Yamashita K, Saito T, Tanaka K, Yamamoto K, Makino T, Kurokawa Y, Eguchi H, Doki Y, Nakajima K. Hayashi Y, et al. Among authors: yamamoto k. Minim Invasive Ther Allied Technol. 2022 Aug;31(6):887-893. doi: 10.1080/13645706.2021.2025402. Epub 2022 Jan 29. Minim Invasive Ther Allied Technol. 2022. PMID: 35098868
Oral frailty is a risk factor for body weight loss after gastrectomy: a single-center, retrospective study.
Teranishi R, Yamamoto K, Kurokawa Y, Uchihashi T, Sugauchi A, Tanikawa C, Kubo K, Takahashi T, Saito T, Momose K, Yamashita K, Tanaka K, Makino T, Nakajima K, Isomura ET, Eguchi H, Doki Y. Teranishi R, et al. Among authors: yamamoto k. Int J Clin Oncol. 2023 Dec;28(12):1625-1632. doi: 10.1007/s10147-023-02413-y. Epub 2023 Oct 25. Int J Clin Oncol. 2023. PMID: 37875767
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.
Teranishi R, Takahashi T, Nishida T, Kurokawa Y, Nakajima K, Koh M, Nishigaki T, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Motoori M, Omori T, Hirota S, Hayashi Y, Takehara T, Eguchi H, Doki Y. Teranishi R, et al. Among authors: yamamoto k. Int J Clin Oncol. 2023 May;28(5):680-687. doi: 10.1007/s10147-023-02325-x. Epub 2023 Mar 27. Int J Clin Oncol. 2023. PMID: 36971916
187 results